2024-05-11 06:25:35
The reports indicate that AstraZeneca will withdraw his vaccines contra Covid-19 a world levelL; in the European Union It can no longer be marketed from this day on.
The pharmaceutical company took this measure arguing that demand for the biological decreased, in addition to registering a surplus of vaccines, according to The Telegraph.
“As multiple updated vaccines have been developed for Covid-19 variants, there is now a surplus of vaccines available. This has caused a decrease in the demand for Vaxzervria, that is no longer manufactured or supplied,” reports the British media.
You might be interested in: LATAM organizations denounce a Chinese company for environmental and social violations
It should be noted that since this May 7th It can no longer be used or marketed in the European Union, after AstraZeneca withdrew authorization for its sale.
The newspaper points out that in the coming months, United Kingdom and other countries that approved the marketing of the AstraZeneca anticovid vaccine will request the withdrawal of the biological from the market.
This news comes after saying laboratory admitted that its vaccine against the virus can cause thrombosis in “very rare cases.”
The above after a legal dispute in a court of Britainin which court documents were cited by The Telegraph.
He thrombosis syndrome with thrombocytopenia (TTS) consists of the formation of clots within the bloodstream, in addition to registering low levels of platelets. The formation of clots is a very dangerous event that can lead to death if they are not detected in time.
You might be interested: AstraZeneca admits that its vaccine against Covid can cause Thrombosis
The class action lawsuit initiated a couple of years ago by people who were vaccinated with this agent occurred after the publication of a study in the journal “The Lancet”; AstraZeneca assured that its vaccine meets an acceptable safety profile and that these cases of thrombosis are “rare.”
LEO
Related
2024-05-11 06:25:35